Renowned physicist Stephen Hawking turns 76 today (Jan. 8) — an age well beyond what he was expected to reach when he was diagnosed with the incurable neurological disease amyotrophic lateral sclerosis (ALS)more than 50 years ago.
Hawking was 21 years old when he was diagnosed with ALS in 1963, and he was given just two years to live. The disease causes the progressive degeneration and death of the nerve cells that control voluntary muscle movements, such as chewing, walking, talking and breathing, according to the National Institute of Neurological Disorders and Stroke (NINDS).
But how has Hawking lived so long with a disease that is typically fatal after just a few years?
In fact, no one knows for certain why Hawking has survived so long with ALS, which is also known as Lou Gehrig's disease. But researchers do know that the progression of the disease varies depending on the person. Although the average life expectancy after a diagnosis of ALS is about three years, about 20 percent of people live five years after their diagnosis, 10 percent live 10 years after their diagnosis and 5 percent live 20 years or more, according to The ALS Association. [The 7 Biggest Mysteries of the Human Body]
One factor that likely plays a role in patients' survival time is genetics; scientists have identified over 20 different genes involved in ALS, said Dr. Anthony Geraci, director of the Neuromuscular Center at Northwell Health's Neuroscience Institute in Manhasset, New York, who is not involved in Hawking's care. "ALS is probably 20 or more different diseases when one considers the genetic underpinnings," Geraci said. Some of these genetic differences appear to affect various aspects of the disease, including survival.
For instance, a gene called SOD1, which is linked with a type of ALS that runs in families, is associated with a more rapid course of the disease, Geraci told Live Science.
Studies have also found that being diagnosed with ALS at a younger age is linked with a longer survival time. (Hawking was relatively young when he was diagnosed with ALS; the disease is most commonly diagnosed in people ages 55 to 75, according to the NINDS.)
The Food and Drug Administration has approved two drugs to treat ALS, called riluzole (Rilutek) and edaravone (Radicava). Each of these drugs can prolog survival by about six months, but the drugs likely don't account for an exceptional survival time like the one Hawking has experienced, Geraci said.
Early symptoms of ALS can include muscle weakness or slurred speech, and eventually, the disease can cause people to lose the ability to move, speak, eat or breathe on their own, according to the Mayo Clinic.
People with ALS typically die from respiratory failure, which occurs when the nerve cells controlling the breathing muscles stop working, or from malnutrition and dehydration, which can occur when the muscles that control swallowing deteriorate, Dr. Leo McCluskey, an associate professor of neurology and medical director of the ALS Center at the University of Pennsylvania, told Scientific American in 2012.
